Cencora (COR) Dividend Yield & History

COR$359.03+10.31 +2.96%
Medical - DistributionLarge Cap
Compare
Market cap$68.51BEnterprise value$73.94BRevenue (TTM)$337.40BMarket positionTop 25%

Score

42
Bearish
Value
38
Quality
42
Growth
47
$359.03Price
$68.51BMarket cap
19.67P/E
18.17Forward P/E
0.67%Dividend yield

Yield is based on dividends paid in the past 12 months. 2026 isn't counted in streaks until the year ends.

Cencora yielded 0.67% at $359.03, on $2.40 a share over the past year.

Cencora raised its yearly dividend every year from 2022 to 2025.

The 13 November 2026 increase took the Cencora quarterly dividend from $0.60 to $0.66, up 10%.

Last year the Cencora dividend was 14% of earnings.

Cencora pays a dividend every quarter.

The next ex-dividend date for Cencora hasn't been announced yet.

The Cencora dividend compounded at 5.8% a year over five years.

Our records cover 107 payments from 2001 to 2026.

At today's yield, $10,000 invested would receive about $67 a year in dividends before tax, if payments stay the same. Dividends can be cut.

Learn: How to read a dividend

Full COR quote · Forecast · Academy

Questions

When did COR last raise the dividend?

The increase was $0.60 to $0.66, dated 13 November 2026.

How often does COR pay a dividend?

Quarterly payments, 4 of them in the past year.

How many years has COR raised the dividend?

In 4 of the last 5 years. 2025 totalled $2.25 a share.

What is the COR dividend yield?

0.67% is the Cencora yield.

Cencora (COR) Dividend Yield & History

COR price $359.03 +10.31 +2.96%

Ticker
COR
Price
$359.03
Change
+10.31 +2.96%
Market cap
$68.51B
P/E
19.67
Forward P/E
18.17
Dividend yield
0.68%
Beta
0.58
Sector
Healthcare
Industry
Medical - Distribution
Stocklytics score
42
Value
38
Quality
42
Growth
47

Stocklytics score rationale: value 38, quality 42, growth 47.

AI Score 75. Cencora, Inc. has a market cap of $67.55 billion and a price of $354, indicating a solid valuation with a price-to-earnings ratio of approximately 19.7

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener